Onconova Therapeutics Price on June 19, 2018
| ONTXDelisted Stock | USD 7.93 0.00 0.00% |
If you're considering investing in Onconova Stock, it is important to understand the factors that can impact its price. As of today, the current price of Onconova Therapeutics stands at 7.93, as last reported on the 18th of April 2024, with the highest price reaching 7.93 and the lowest price hitting 7.93 during the day. Onconova Therapeutics is out of control given 3 months investment horizon. Onconova Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.15, which implies the firm had a 0.15% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-five different technical indicators, which can help you to evaluate if expected returns of 13.94% are justified by taking the suggested risk. Use Onconova Therapeutics Coefficient Of Variation of 774.09, risk adjusted performance of 0.0914, and Semi Deviation of 0.9552 to evaluate company specific risk that cannot be diversified away.
Onconova Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Onconova |
Sharpe Ratio = 0.1457
| Best Portfolio | Best Equity | ONTX | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 95.71 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.07 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Onconova Therapeutics is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Onconova Therapeutics by adding it to a well-diversified portfolio.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
About Onconova Therapeutics Stock history
Onconova Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Onconova is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Onconova Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Onconova Therapeutics stock prices may prove useful in developing a viable investing in Onconova Therapeutics
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. Onconova Therapeutics, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania. Onconova Therapeutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Onconova Therapeutics Stock Technical Analysis
Onconova Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Onconova Therapeutics Period Price Range
Onconova Therapeutics April 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Onconova Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Onconova Therapeutics shares will generate the highest return on investment. By undertsting and applying Onconova Therapeutics stock market strength indicators, traders can identify Onconova Therapeutics entry and exit signals to maximize returns
Onconova Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Onconova Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Onconova Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Onconova to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0914 | |||
| Jensen Alpha | 11.82 | |||
| Total Risk Alpha | 4.89 | |||
| Sortino Ratio | 3.0 | |||
| Treynor Ratio | (0.68) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Onconova Stock
If you are still planning to invest in Onconova Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Onconova Therapeutics' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |